COVID-19 Vaccine Associated Cerebral Venous Thrombosis

Cerebral Venous Thrombosis A type of stroke in which the venous channels of the brain become thrombosed, resulting in cerebral infarction in the areas corresponding to the thrombosis.

Cerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19

Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin based anticoagulation

Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine

Cerebral venous sinus thrombosis after vaccination: the United Kingdom experience

US case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020

Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET)

Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review

Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S

A rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccination

Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom

Diagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccination

COVID-19 vaccination: information on the occurrence of arterial and venous thrombosis using data from VigiBase

Cerebral venous thrombosis associated with the covid-19 vaccine in Germany

Cerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event

The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination

Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in an elderly, non-comorbid Indian male treated with conventional heparin-warfarin-based anticoagulation

Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after covid-19 vaccination; a systematic review.

A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated with administration of COVID-19 vaccine

Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine.

Cerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford-AstraZeneca COVID-19: a missed opportunity for a rapid return on experience

Diagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopenia

Venous sinus thrombosis after vaccination with ChAdOx1 nCov-19

Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency

Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study

Cerebral venous thrombosis associated with COVID-19 vaccine in Germany

Malignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia

Cerebral venous sinus thrombosis associated with thrombocytopenia after COVID-19 vaccination.

central venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental

Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation

Cerebral venous sinus thrombosis 2 weeks after first dose of SARS-CoV-2 mRNA vaccine

Deep venous thrombosis (DVT) occurring shortly after second dose of SARS-CoV-2 mRNA vaccine

Vaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high mortality rate: a case series.

Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis.

Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine.

Cerebral venous thrombosis following COVID-19 vaccination.

Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, centered on cerebral venous sinus thrombosis (CVST)

Cerebral venous thrombosis associated with COVID-19 vaccine in Germany.

Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management.

Cerebral venous thrombosis and thrombocytopenia after COVID-19 vaccination.

Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom.

Cerebral venous thrombosis induced by SARS-CoV-2 vaccine.

Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia

Cerebral venous thrombosis after the BNT162b2 mRNA SARS-CoV-2 vaccine.

Cerebral venous thrombosis after COVID-19 vaccination

Lethal cerebral venous sinus thrombosis after COVID-19 vaccination

Cerebral venous sinus thrombosis in the U.S. population, After SARS-CoV-2 vaccination with adenovirus and after COVID-19

Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular administration of the vaccine.

Central venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental

Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first brain MRI

Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S

Cerebral venous sinus thrombosis associated with post-vaccination thrombocytopenia by COVID-19.

Cerebral venous sinus thrombosis 2 weeks after the first dose of SARS-CoV-2 mRNA vaccine.

Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)

Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency

A rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination

Massive cerebral venous thrombosis and venous basin infarction as late complications of COVID-19: a case report

Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia

Cerebral venous thrombosis developing after vaccination. COVID-19: VITT, VATT, TTS and more

Cerebral venous thrombosis and myeloproliferative neoplasms: a three-center study of 74 consecutive cases.

Vaccine-induced cerebral venous thrombosis and thrombocytopenia. Oxford-AstraZeneca COVID-19: a missed opportunity for rapid return on experience

Case report: Take a second look: Cerebral venous thrombosis related to Covid-19 vaccination and thrombotic thrombocytopenia syndrome